abdualrahman

[Journal of Clinical Investigation @jclinicalinvest]

How might SGLT2 inhibitors mediate cardiorenal benefits beyond glucose lowering?

https://t.co/qsX8AtsguY
Abdualrahman Mohammed Abdualkader @armak1983 Rami Al Batran @AlbatranLab & team @UMontreal report that SGLT2 inhibitors boost ketone production by directly activating a liver enzyme.

The cover image shows the crystal structure of human mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase 2 (HMGCS2) homodimer (rainbow ribbons) bound to empagliflozin (gray sticks).
#SGLT2i #Ketogenesis #CardioMetabolic #KidneyDisease #LiverMetabolism

[Journal of Clinical Investigation @jclinicalinvest]

@armak1983 @AlbatranLab @UMontreal Behind the scenes: Dr. Abdualkader @armak1983, a pharmaceutical chemist and Research Associate at Université de Montréal, works at the interface of drug design for the management of metabolic disorders.

[abdualrahman @armak1983]

@Dolani_AA @jdpereira And it was nice!

[abdualrahman @armak1983]

@amdo1984 Same here ... It is green 😆

[abdualrahman @armak1983]

@amdo1984 @jdpereira To add, there no alternative to Turkish coffee. Any other option will not make it real coffee!

[abdualrahman @armak1983]

@amdo1984 @jdpereira I completely agree with you. Having worked in the industry for three years before transitioning to academia for the past two years, I have experienced firsthand how academic life is becoming increasingly burning and stressful.

[abdualrahman @armak1983]

@amdo1984 Interesting! All the best.

[abdualrahman @armak1983]

@amdo1984 هاي هي .... واق واق واق ....

[abdualrahman @armak1983]

@amdo1984
tweet...tweet...tweet...

[abdualrahman @armak1983]

Novel nano-carrier platform shows promise for cancer drug delivery http://t.co/IHoVFYNe

[abdualrahman @armak1983]

Tweets